← All instruments
Dividend per share, restated for any split or bonus that came after — so a pre-split payout is comparable with a post-split one. Latest year on record: FY26.
Hikal Limited
₹232.58
▲ 1.77%
Delayed · as of 05 Aug 2026
Dividend per share by financial year
| Financial year | Total dividend |
|---|---|
| FY02 | ₹0.93 |
| FY06 | ₹0.47 |
| FY07 | ₹0.40 |
| FY08 | ₹0.87 |
| FY09 | ₹0.53 |
| FY11 | ₹1.07 |
| FY12 | ₹0.80 |
| FY13 | ₹0.80 |
| FY14 | ₹0.60 |
| FY15 | ₹0.33 |
| FY16 | ₹0.67 |
| FY17 | ₹1.07 |
| FY18 | ₹0.87 |
| FY19 | ₹1.10 |
| FY20 | ₹1.60 |
| FY21 | ₹1.20 |
| FY22 | ₹2.20 |
| FY23 | ₹1.00 |
| FY24 | ₹1.20 |
| FY25 | ₹1.20 |
| FY26 | ₹1.00 |
Dividend history
1–20 of 38| Type | Amount (adjusted) | Ex-date / source | Record date | Payment date | FY |
|---|---|---|---|---|---|
| INTERIM | ₹0.20 | 17 Feb 2026NSE source ↗Also reported by BSE | |||
| FINAL | ₹0.80 | 02 Sep 2025NSE source ↗Also reported by BSE | |||
| INTERIM | ₹0.60 | 07 Feb 2025NSE source ↗Also reported by BSE | |||
| FINAL | ₹0.60 | 04 Sep 2024NSE source ↗Also reported by BSE | |||
| INTERIM | ₹0.60 | 20 Feb 2024NSE source ↗Also reported by BSE | |||
| FINAL | ₹0.60 | 18 Sep 2023NSE source ↗Also reported by BSE | |||
| INTERIM | ₹0.60 | 14 Feb 2023NSE source ↗Also reported by BSE | |||
| FINAL | ₹0.40 | 14 Sep 2022NSE source ↗Also reported by BSE | |||
| INTERIM | ₹1.20 | 23 Feb 2022NSE source ↗Also reported by BSE | |||
| FINAL | ₹1.00 | 25 Aug 2021NSE source ↗Also reported by BSE | |||
| INTERIM | ₹1.00 | 15 Feb 2021NSE source ↗Also reported by BSE | |||
| FINAL | ₹0.20 | 07 Sep 2020NSE source ↗Also reported by BSE | |||
| INTERIM | ₹1.00 | 17 Feb 2020NSE source ↗Also reported by BSE | |||
| FINAL | ₹0.60 | 23 Jul 2019NSE source ↗Also reported by BSE | |||
| INTERIM | ₹0.60 | 13 Feb 2019NSE source ↗Also reported by BSE | |||
| FINAL | ₹0.50 | 31 Jul 2018NSE source ↗Also reported by BSE | |||
| INTERIM | ₹0.47* | 21 Feb 2018NSE source ↗Also reported by BSE | |||
| FINAL | ₹0.40* | 02 Aug 2017NSE source ↗Also reported by BSE | |||
| INTERIM | ₹0.40* | 13 Feb 2017NSE source ↗Also reported by BSE | |||
| FINAL | ₹0.33* | 02 Aug 2016NSE source ↗Also reported by BSE |
Amounts marked *were restated for a later split or bonus so they compare with today’s shares. Switch to “as filed” to see what was actually declared at the time — that is the figure on an old broker statement.
Other corporate actions
2 on record| Action | Ratio | Ex-date | Record date |
|---|---|---|---|
| Bonus issuehistory adjusted | 1:2 — 1 free share for every 2 held | 22 Jun 2018 | |
| Stock splithistory adjusted | 1:5 — one share became 5 | 27 Feb 2015 |
Splits and bonuses change the share count, so payouts declared before one are restated in the chart above to stay comparable. Buybacks, rights issues and mergers are listed for reference and do not affect those figures.
Others in Pharmaceuticals
Ranked by published trailing-12-month yield. Classification is factual, not a recommendation.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.